Microtubule-Targeting Agents Enter the Central Nervous System (CNS): Double-edged Swords for Treating CNS Injury and Disease

키워드

참고문헌 (40)

1. Dumontet C, "Microtubule-binding agents: a dynamic field of cancer therapeutics", Nat Rev Drug Discov, 9, pp.790~803 (2010)
2. Brunden KR, "Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies", Biochem Soc Trans, 40, pp.661~666 (2012)
3. Hellal F, "Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury", Science, 331, pp.928~931 (2011)
4. Zhang B, "Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model", Proc Natl Acad Sci, 102, pp.227~231 (2005)
5. Sahenk Z, "Axonal tubulin and microtubules: morphologic evidence for stable regions on axonal microtubules", Cell Motil Cytoskeleton, 8, pp.155~164 (1987)
6. Maday S, "Axonal transport: cargo-specific mechanisms of motility and regulation", Neuron, 84, pp.292~309 (2014)
7. Hur EM, "GSK3 controls axon growth via CLASP-mediated regulation of growth cone microtubules", Genes Dev, 25, pp.1968~1981 (2011)
8. Kleele T, "An assay to image neuronal microtubule dynamics in mice", Nat Commun, 5, pp.4827~ (2014)
9. Brady ST, "Axonal tubulin and axonal microtubules: biochemical evidence for cold stability", J Cell Biol, 99, pp.1716~1724 (1984)
10. Song Y, "Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules", Neuron, 78, pp.109~123 (2013)
11. Baas PW, "Microtubule stability in the axon: new answers to an old mystery", Neuron, 78, pp.3~5 (2013)
12. Ertürk A, "Disorganized microtubules underlie the formation of retraction bulbs and the failure of axonal regeneration", J Neurosci, 27, pp.9169~9180 (2007)
13. Duncan JE, "The genetics of axonal transport and axonal transport disorders", PLoS Genet, 2, pp.e124~ (2006)
14. Cederquist GY, "An inherited TUBB2B mutation alters a kinesin-binding site and causes polymicrogyria, CFEOM and axon dysinnervation", Hum Mol Genet, 21, pp.5484~5499 (2012)
15. Tischfield MA, "Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance", Cell, 140, pp.74~87 (2010)
16. Fanara P, "Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis", J Biol Chem, 282, pp.23465~23472 (2007)
17. Sun F, "Neuronal intrinsic barriers for axon regeneration in the adult CNS", Curr Opin Neurobiol, 20, pp.510~518 (2010)
18. Yiu G, "Glial inhibition of CNS axon regeneration", Nat Rev Neurosci, 7, pp.617~627 (2006)
19. Cregg JM, "Functional regeneration beyond the glial scar", Exp Neurol, 253, pp.197~207 (2014)
20. Hur EM, "Engineering neuronal growth cones to promote axon regeneration over inhibitory molecules", Proc Natl Acad Sci, 108, pp.5057~5062 (2011)
21. Sengottuvel V, "Taxol facilitates axon regeneration in the mature CNS", J Neurosci, 31, pp.2688~2699 (2011)
22. Leon S, "Lens injury stimulates axon regeneration in the mature rat optic nerve", J Neurosci, 20, pp.4615~4626 (2000)
23. Popovich PG, "Independent evaluation of the anatomical and behavioral effects of Taxol in rat models of spinal cord injury", Exp Neurol, 261, pp.97~108 (2014)
24. Millecamps S, "Axonal transport deficits and neurodegenerative diseases", Nat Rev Neurosci, 14, pp.161~176 (2013)
25. Lee VM, "Neurodegenerative tauopathies", Annu Rev Neurosci, 24, pp.1121~1159 (2001)
26. Biernat J, "Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding", Neuron, 11, pp.153~163 (1993)
27. Buee L, "Tau protein isoforms, phosphorylation and role in neurodegenerative disorders", Brain Res Brain Res Rev, 33, pp.95~130 (2000)
28. Andrieux A, "Microtubule stabilizer ameliorates synaptic function and behavior in a mouse model for schizophrenia", Biol Psychiatry, 60, pp.1224~1230 (2006)
29. Brunden KR, "Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy", J Neurosci, 30, pp.13861~13866 (2010)
30. Dauer W, "Parkinson’s disease: mechanisms and models", Neuron, 39, pp.889~909 (2003)
31. Ren Y, "Selective vulnerability of dopaminergic neurons to microtubule depolymerization", J Biol Chem, 280, pp.34105~34112 (2005)
32. Cartelli D, "Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective", Sci Rep, 3, pp.1837~ (2013)
33. Alim MA, "Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein", J Alzheimers Dis, 6, pp.435~442 (2004)
34. Gillardon F, "Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability: a point of convergence in parkinsonian neurodegeneration?", J Neurochem, 110, pp.1514~1522 (2009)
35. Yang F, "Parkin stabilizes microtubules through strong binding mediated by three independent domains", J Biol Chem, 280, pp.17154~17162 (2005)
36. Godena VK, "Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations", Nat Commun, 5, pp.5245~ (2014)
37. Ren Y, "Parkin binds to alpha", beta tubulin and increases their ubiquitination and degradation, 2003, pp.23, 3316~3324
38. Kudlowitz D, "Defining risks of taxane neuropathy: insights from randomized clinical trials", Clin Cancer Res, 19, pp.4570~4577 (2013)
39. Hershman DL, "Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline", J Clin O ncol, 32, pp.1941~1967 (2014)
40. Carlson K, "Peripheral neuropathy with microtubule-targeting agents: occurrence and management approach", Clin Breast Cancer, 11, pp.73~81 (2011)

관련 논문AI추천